THOUSAND OAKS, Calif., April 19, 2023 /PRNewswire/ -- Amgen (AMGN) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the ...
THOUSAND OAKS, Calif., Aug. 20, 2024 /PRNewswire/ -- Amgen (AMGN) today announced Otezla ® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results